Clinical Trial Update: A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for NeuroVax, a therapeutic TCR peptide vaccine being studied in secondary progressive and general multiple sclerosis, across Phase 2 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• NeuroVax

Snippet

Sponsor: Immune Response BioPharma, Inc. | Conditions: Secondary Progress Multiple Sclerosis, Multiple Sclerosis | Phase 2, Phase 3 | Status: UNKNOWN